Santen Named S&P Global Sustainability Yearbook Member for 2026

February 27, 2026 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter Santen) announced today that it has been named a Sustainability Yearbook Member 2026 in the sustainability ratings published by S&P Global, a leading global research and rating company based in the United States. This is the fifth consecutive year that Santen has been named a Sustainability Yearbook Member.

S&P Global publishes an annual Sustainability Yearbook that evaluates the sustainability efforts of companies worldwide from three perspectives – governance & economic, environmental, and social – while featuring and recognizing particularly outstanding leaders in sustainability. For the 2026 rankings, evaluations were conducted on more than 9,200 companies. Of these, 848 companies ranked within the top 15% were selected as Yearbook Members. Collectively, these companies represent 59 industries – including 23 in the pharmaceutical sector.

The 2026 Emblem

Being consistently chosen for inclusion in the S&P Global Sustainability Yearbook, a globally recognized sustainability assessment benchmark, demonstrates that Santen’s initiatives meet the high standards established by international evaluation criteria. Santen will continue to position sustainability at the heart of its corporate activities, contributing to the eye health of people worldwide while accelerating its efforts to realize a sustainable society. For more information about Santen’s sustainability initiatives, please visit https://www.santen.com/en/sustainability.

About Santen
Santen is a global pharmaceutical company committed to advancing eye health and improving lives through better vision. Founded in 1890 in Osaka, Japan, Santen makes use of more than 135 years of experience in research and development, manufacturing, and marketing of pharmaceuticals and medical devices to help people around the globe maintain and improve their eye health. Santen focuses exclusively on eye health and its portfolio includes glaucoma, dry eye, infection, allergy, age-related macular degeneration, and myopia. Santen’s products and services are available in more than 60 countries and regions. Guided by its Core Principle “Tenki ni sanyo suru” – Exploring the secrets and mechanisms of nature in order to contribute to people’s health – Santen combines its expertise with deep patient focus to contribute to the realization of “Happiness with Vision.”
For more information, please visit https://www.santen.com/en.

Contact
Corporate Communications
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com